[태그:] Neurodevelopmental Disorders (NDDs)
-
![[Clinical Review] Why WGS Achieves up to 44.4% Diagnostic Yield in NDD: Insights from a 100-Family Italian Study](https://d15q5w6b9vqac5.cloudfront.net/wp-content/uploads/2024/09/26201254/Siri%EC%8D%B8%EB%84%A4%EC%9D%BC26.webp)
[Clinical Review] Why WGS Achieves up to 44.4% Diagnostic Yield in NDD: Insights from a 100-Family Italian Study
🎯 Key Highlights Prioritization of WGS: For patients with Neurodevelopmental Disorders (NDDs)—particularly those with comorbid Intellectual Disability (ID)—Whole Genome Sequencing (WGS) serves as the most powerful first-tier diagnostic tool, providing an approximate 10% increase in diagnostic yield over conventional testing methods. Necessity of Trio Analysis: Precise interpretation through Trio-based analysis is essential, as complex variants…